This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Gemifloxacin offers advantages over clarithromycin for AECB. Pharmacoecon. Outcomes News 331, 3–4 (2001). https://doi.org/10.1007/BF03269584
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269584